Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a computer help dementia patients remember and connect?

NCT ID NCT04769466

Symptom relief Sponsor: Benjamin Rose Institute on Aging Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested an online platform called LifeBio Memory that helps collect life stories from people with dementia. The platform uses machine learning to turn spoken memories into personalized storybooks. Researchers wanted to see if this tool could improve mood, reduce agitation, and strengthen bonds between residents, staff, and families in nursing homes. A total of 234 participants (residents and staff) took part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
LifeBio Memory digital reminiscence therapy platform
What this could lead to
If it works, this could offer a simple, low-cost way to improve mood and communication for people with dementia in nursing homes.
What could go wrong
This is a small, completed feasibility study, not a large-scale trial. The benefits may not hold up in broader use, and the platform requires staff training and engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

234 people

The number who actually took part.

Started

Mar 2022

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 112 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Staff): * Work within a residential care facility participating in the study * Speak and read English * Able to provide own transportation to and from interviews with residents Inclusion Criteria (Residents * Must reside within a participating residential care facility * Must be at least 55 years of Age * Must speak and read English * Have a Dementia diagnosis * Have a Score of at least 15 on the Mini Mental State Examination Exclusion Criteria (Residents) * Residents will be excluded from the study if they show signs of rapid cognitive decline or physical deterioration over the last 6 months, as evidence by information gained during screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive impairment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive impairment Dementia

Contacts and locations

Locations

  • Benjamin Rose Institute on Aging

    Cleveland, Ohio, 44120, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.